Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC

被引：0
|
作者：
Yaqun Zhang
Lingfan Xu
Yan Chang
YanJing Li
William Butler
Er Jin
Aifen Wang
Yulei Tao
Xufeng Chen
Chaozhao Liang
Jiaoti Huang
机构：
[1] Beijing Hospital,Department of Urology
[2] National Center of Gerontology,Department of Pathology
[3] Duke University Medicine,Department of Urology
[4] the First Affiliated Hospital of Anhui Medical University,Institute of Clinical Pharmascology
[5] Anhui Medical University,Department of Respiratory Medicine
[6] Hangzhou First People’s Hospital,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：160 / 171
页数：11
相关论文
共 50 条
  • [31] Targeting mutant p53 for efficient cancer therapy
    Bykov, Vladimir J. N.
    Eriksson, Sofi E.
    Bianchi, Julie
    Wiman, Klas G.
    NATURE REVIEWS CANCER, 2018, 18 (02) : 89 - 102
  • [32] Targeting mutant p53 through the mevalonate pathway
    Freed-Pastor, William
    Prives, Carol
    NATURE CELL BIOLOGY, 2016, 18 (11) : 1122 - 1124
  • [33] Targeting mutant p53 stabilization for cancer therapy
    Wang, Jiajian
    Liu, Wenjun
    Zhang, Lanqing
    Zhang, Jihong
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [34] Targeting mutant p53 for efficient cancer therapy
    Vladimir J. N. Bykov
    Sofi E. Eriksson
    Julie Bianchi
    Klas G. Wiman
    Nature Reviews Cancer, 2018, 18 : 89 - 102
  • [35] Regulation of Mutant p53 Protein Expression
    Vijayakumaran, Reshma
    Tan, Kah Hin
    Miranda, Panimaya Jeffreena
    Haupt, Sue
    Haupt, Ygal
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [36] Targeting mutant p53 in cancer: the latest insights
    Di Agostino, Silvia
    Fontemaggi, Giulia
    Strano, Sabrina
    Blandino, Giovanni
    D'Orazi, Gabriella
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [37] Targeting mutant p53 in cancer: the latest insights
    Silvia Di Agostino
    Giulia Fontemaggi
    Sabrina Strano
    Giovanni Blandino
    Gabriella D’Orazi
    Journal of Experimental & Clinical Cancer Research, 38
  • [38] Role of Thiol Reactivity for Targeting Mutant p53
    Zhang, Qiang
    Bergman, Jan
    Wiman, Klas G.
    Bykov, Vladimir J. N.
    CELL CHEMICAL BIOLOGY, 2018, 25 (10): : 1219 - +
  • [39] Targeting mutant p53 through the mevalonate pathway
    William Freed-Pastor
    Carol Prives
    Nature Cell Biology, 2016, 18 : 1122 - 1124
  • [40] Targeting Oncogenic Mutant p53 for Cancer Therapy
    Parrales, Alejandro
    Iwakuma, Tomoo
    FRONTIERS IN ONCOLOGY, 2015, 5
12345